On January 13, 2016, the leading 3D biological print Organovo announced that its wholly owned subsidiary of Samsara Sciences begin commercial operations.We have learned, Samsara will focus on providing 3D printing human liver cells.According to understand, Organovo is officially released in November 2014 to commercial 3D printing human liver tissue.The product is mainly used in preclinical drug discovery test. Organovo are currently working with the Yale school of medicine development can be used in surgical transplant research biological printing organization.
3D printing technology is becoming prevailing in our daily life, the typical representative is the cheap 3D pens. Many people experience the miracle of 3D printing technology through it. Now, this technique is applied in more fields.
According to the 3D printing net understood, the person’s liver contains a variety of cells, including some of 3D printing, and the business of Samsara will only make 3D printing hepatic stellate cell – this is a kind of one that can become active cells after liver injury.In a healthy liver, hepatic stellate cells generally dormant, known as static state.When liver damage, however, these cells can activation and proliferation, produce scar tissue.Cells in fatty liver disease and fibrosis of liver disease development plays an important role.